» Articles » PMID: 1649088

Nitroxide SOD-mimics: Modes of Action

Overview
Specialty Chemistry
Date 1991 Jan 1
PMID 1649088
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Low molecular weight superoxide dismutase mimics have been shown to afford protection from oxidative damage. Such SOD-mimics can readily permeate cell membrane achieving sufficiently high levels both inside and outside the cell to effectively detoxify intracellular O2-.. Preliminary findings also indicated that metal-based and metal-free SOD-mimics can protect hypoxic cells from H2O2-induced damage. The present study explored the possibility that SOD-mimics such as desferrioxamine-Mn(III) chelate [DF-Mn] or cyclic nitroxide stable free radicals could protect from O2-.-independent damage. Killing of monolayered V79 Chinese hamster cells was induced by H2O2 or by t-butyl hydroperoxide (t-BHP) and assayed clonogenically. Neither catalase nor native SOD protected the cells from t-BHP. In contrast, both DF-Mn and cyclic nitroxides protected suggesting cytotoxic processes independent of O2-. or of O2-.-derived active species. The inhibition of the damage by both metal-free and metal-based SOD mimics is attributable to either SOD-mimic reacting with reduced transition metal to block the Fenton reaction and/or intercepting and detoxifying intracellular organic free radicals.

Citing Articles

Superoxide dismutase and neurological disorders.

Chidambaram S, Anand N, Varma S, Ramamurthy S, Vichitra C, Sharma A IBRO Neurosci Rep. 2024; 16:373-394.

PMID: 39007083 PMC: 11240301. DOI: 10.1016/j.ibneur.2023.11.007.


Effect of Low Concentration of Nitroxides on SH-SY5Y Cells Transfected with the Tau Protein.

Bartosz G, Pienkowska N, Kut K, Cieniek B, Stefaniuk I, Sadowska-Bartosz I Int J Mol Sci. 2023; 24(23).

PMID: 38069000 PMC: 10706669. DOI: 10.3390/ijms242316675.


Nitric oxide synthase and reduced arterial tone contribute to arteriovenous malformation.

Huang L, Cheng F, Zhang X, Zielonka J, Nystoriak M, Xiang W Sci Adv. 2023; 9(21):eade7280.

PMID: 37235659 PMC: 10219588. DOI: 10.1126/sciadv.ade7280.


Pilot trial of topical MTS‑01 application to reduce dermatitis in patients receiving chemoradiotherapy for stage I‑III carcinoma of the anal canal.

Citrin D, Valle L, Camphausen K, Cooley-Zgela T, Smart D, Yao M Int J Oncol. 2022; 60(6).

PMID: 35438186 PMC: 9081975. DOI: 10.3892/ijo.2022.5358.


Reactivity of redox sensitive paramagnetic nitroxyl contrast agents with reactive oxygen species.

Nyui M, Nakanishi I, Anzai K, Ozawa T, Matsumoto K J Clin Biochem Nutr. 2019; 64(1):13-19.

PMID: 30705507 PMC: 6348418. DOI: 10.3164/jcbn.17-135.